Dyadic Collaborating with Jiangsu Hengrui Medicine for Biologic Drug Development
Dyadic International Inc. (NASDAQ:DYAI), a global biotechnology company focused on further applying its proprietary C1 gene expression platform to accelerate
Read More
Author: PHStocks
Shi Dashenghua Sole Supplier of Solvents and Additives in Tesla’s New Battery
ACN Newswire A Tesla battery expert said that a large amount of the solvent DMC (dimethyl carbonate) will be used
Read MoreSGX-Listed OIO Holdings Launches Beta Test Program of Enterprise Cryptocurrency Wallet
Singapore Exchange (SGX)-listed OIO Holdings Limited has announced the beta test launch of Moonstake Enterprise Wallet, a cryptocurrency wallet for
Read More
Tiger Brokers Singapore Adds ASX to its Online and Mobile Trading Apps
Xiaomi-backed Tiger Brokers, a global online stock brokerage, has announced adding the Australian Securities Exchange (ASX) to its online and
Read More
TRI-AD Office Wins “Creative Office Award” at 33rd Nikkei New Office Awards
Toyota Research Institute – Advanced Development Inc. (TRI-AD) has received the “Creative Office Award” at the 33rd Nikkei New Office
Read More
Denyo and Toyota Jointly Develop and Start Verification Tests for Fuel Cell Power Supply Vehicle that Uses Hydrogen to Generate Electricity
Denyo Co. Ltd and Toyota Motor Corp. have jointly developed a fuel cell power supply vehicle that uses hydrogen to
Read MoreHuge Decrease in Levels of Streaming Piracy Seen in Malaysia Over the Last 12 Months
A new study of the online content viewing behaviour of Malaysian consumers has found a massive 64% decrease in consumers
Read MoreEisai Establishes Pharma Sales Subsidiary in Vietnam
Eisai Co. Ltd has established a new pharmaceutical sales subsidiary in Ho Chi Minh City, the Socialist Republic of Viet
Read More
Cleantech Group Names TRENDE a 2020 APAC 25 Company
TRENDE Inc., an online renewable energy retailer in Japan, has just been included in the 2020 APAC 25 list produced
Read MoreNanoViricides Nominates Novel Candidate for Advancing Into Clinical Trials for COVID-19 Treatment
NanoViricides Inc. (NYSEAmerican:NNVC) a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform,
Read More